| PERIOD ENDING | 30-Sep-08 | 31-Dec-07 | | Total Revenue | 6,263,000 | 1,488,000 | | Cost of Revenue | 1,538,000 | 416,000 | | | Gross Profit | 4,725,000 | 1,072,000 | | | Operating Expenses | | Research Development |
-
|
-
| | Selling General and Administrative | 1,786,000 | 386,000 | | Non Recurring | 1,470,000 |
-
| | Others | 237,000 |
-
| | | | Total Operating Expenses |
-
|
-
| | | | Operating Income or Loss | 1,232,000 | 686,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 246,000 | 41,000 | | Earnings Before Interest And Taxes | 1,479,000 | 728,000 | | Interest Expense | 143,000 | 45,000 | | Income Before Tax | 1,336,000 | 683,000 | | Income Tax Expense | 532,000 | 259,000 | | Minority Interest |
-
|
-
| | | | Net Income From Continuing Ops | 804,000 | 424,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
| | Extraordinary Items |
-
|
-
| | Effect Of Accounting Changes |
-
|
-
| | Other Items |
-
|
-
| | | | Net Income | 804,000 | 424,000 | | Preferred Stock And Other Adjustments |
-
|
-
| | | Net Income Applicable To Common Shares | $804,000 | $424,000 |
|
0.26% Nasdaq 
Income Statement
